healthcare

clinical trials

Why Array Is Making a Run

Array BioPharma Inc. (NASDAQ: ARRY) is watching its shares make a handy gain on Friday after making a key U.S. Food and Drug Administration (FDA) submission. The company announced the ...
Read Full Story »
Female patient on gurney

Ampio Crashes After Late-Stage Trial Failure

Ampio Pharmaceuticals, Inc. (NYSEMKT: AMPE) is watching its shares get cut in half on Thursday after news of a failed late-stage trial. The company announced the results of its Ampion PIVOT ...
Read Full Story »
Doctor, Health (pulse) copy

Bioventus Files for IPO

Bioventus Inc. filed a Form S-1 with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering. There were no pricing details given in the filing but the offering ...
Read Full Story »
clinical trials

Lipocine Crashes After Receiving CRL From the FDA

Lipocine Inc. (NASDAQ: LPCN) is watching its shares get cut in half in Wednesday’s session after receiving a letter from the U.S. Food and Drug Administration (FDA). The company announced ...
Read Full Story »
Female patient on gurney

Is Galena Dead in the Water After This Failed Trial?

Galena Biopharma, Inc. (NASDAQ: GALE) is absolutely crashing on Wednesday after the company released further information regarding its Breast Cancer clinical trial. The company announced the recommendation from the Independent ...
Read Full Story »
Medicine pills

Eli Lilly Rises on Positive FDA Committee Vote

Eli Lilly and Co. (NYSE: LLY) is watching its shares make a decent gain on Wednesday following a U.S. Food and Drug Administration (FDA) vote. The FDA Advisory Committee voted ...
Read Full Story »
doctor

Why Tesaro Is Skyrocketing

Tesaro, Inc. (NASDAQ: TSRO) is watching its shares make a significant gain on Wednesday after the company released positive late-stage trial results. The company announced that its Phase 3 NOVA ...
Read Full Story »
biotech word cloud

Why Regulus Is Tanking

Regulus Therapeutics Inc. (NASDAQ: RGLS) saw its shares cut in half early Tuesday morning following news of a clinical hold from the U.S. Food and Drug Administration (FDA). The company ...
Read Full Story »
reprimand

Are Businesses More Worried About Regulation and Health Care Than About the Economy or Low Energy Prices?

Have you ever heard that politicians will only give the answers to the questions they want to answer, regardless of the question? It seems that businesses may now be in ...
Read Full Story »
health square image copy

Medtronic Moves to Acquire Heartware

Heartware International (NASDAQ: HTWR) is watching its shares absolutely skyrocket in Monday’s session despite the huge market downturn from the Brexit. This surge is the result of Medtronic PLC (NYSE: ...
Read Full Story »
health care

Medpace Files for IPO

Medpace Holdings, Inc. filed a Form S-1 with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). There were no pricing details mentioned in the filing but the ...
Read Full Story »
Prescription Drugs, Pills

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

The short interest data have been released for the June 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
biotech word cloud

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the June 15 settlement date. Biotech companies are considered a riskier group of stocks, with big potential upside and big potential downside. After ...
Read Full Story »
Law and Marijuana

Marijuana News Roundup: Democrats Add Pot Law Reform to Platform

The Democratic National Committee on Saturday approved a party platform plank calling for marijuana law reform. All 15 members of the platform drafting committee, including the 7 appointed by Senator ...
Read Full Story »
cannabis plants

Marijuana Price Ticks Down Again

For the week ended Friday, June 24, the spot price index for a pound of cannabis decreased 0.5% from $1,978 in the prior week to $1,969. According to the analysts ...
Read Full Story »